Researchers of the Wyss Institute of Harvard University and of the Harvard John a.. Paulson School of Endineering and Applied Sciences (SEAS), they have developed a way to administer insulin in a pill form, substantially improving the methodology currently used to maintain levels of blood sugar in people suffering from diabetes. The oral administration of this protein had been difficult to achieve, Since is not developed well in the acidic environment of the stomach and has low absorption in the intestine. The new formulation is biocompatible, easy to create and can be stored up to two months at room temperature, which is much more than what currently insulin injections can last.